Ovid Therapeutics Inc.
OVID · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,158 | -$4,684 | -$10,235 | -$9,253 |
| Dep. & Amort. | $17 | $99 | $141 | $147 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,219 | $1,284 | $0 |
| Change in WC | -$1,691 | -$1,244 | -$1,303 | -$853 |
| Other Non-Cash | $960 | -$164 | -$167 | -$49 |
| Operating Cash Flow | -$12,872 | -$4,774 | -$10,280 | -$10,008 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$4,947 | -$4,947 | -$4,898 | -$16,713 |
| Inv. Sales/Matur. | $10,000 | $17,000 | $10,000 | $38,000 |
| Other Inv. Act. | $0 | $0 | $0 | $1 |
| Investing Cash Flow | $5,053 | $12,053 | $5,102 | $21,292 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $15 | $0 | $13 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $15 | $0 | $13 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$7,804 | $7,279 | -$5,165 | $11,284 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $28,415 | $23,067 | $28,232 | $15,017 |
| End Cash | $20,611 | $30,346 | $23,067 | $26,301 |
| Free Cash Flow | -$12,872 | -$4,774 | -$10,280 | -$10,030 |